Келесіні WhatsApp арқылы жіберу
Сөйлесуді жалғастыруhttps://www.bjh.be/the-bispecific-antibody-mosunetuzumab-exhibits-promising-activity-in-heavily-pretreated-non-hodgkin-lymphoma
https://www.bjh.be/the-bispecific-antibody-mosunetuzumab-exhibits-promising-activity-in-heavily-pretreated-non-hodgkin-lymphoma